Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 JUL 6 ... of anthrax. Emergent's development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia. Additional information may be found ...
2009 SEP 21 ... baby who has stopped eating for no apparent reason is diagnosed with an unlikely case of botulism. A seemingly healthy baby, suddenly covered with blisters, is diagnosed with a form of ...
2009 NOV 1 ... company's research activities towards development of a small molecule antidote to treat botulism, which is a worldwide threat as the US fights the War on Terrorism. The one-year, $1.6M ...
2009 AUG 4 ... year, with sales up more than 40%. A number of well-publicized outbreaks of equine botulism in the past year and a focused marketing response contributed to a double-digit increase ...
2009 OCT 5 ... a 60% increase in sales of the company's two veterinary biologics: BotVax B, an equine botulism vaccine, and EqStim , an immune system stimulant. The quarter-over-quarter increase also ...
2009 NOV 29 ... environment, can also cause serious infectious diseases, such as tetanus, anthrax, and botulism. Now researchers from Lund University and the U.S. have made a breakthrough in our ...
2009 OCT 13 ... Clostridium botulinum type B strains, including 3 isolates associated with infant botulism in Japan, were genetically characterized by phylogenetic analysis of boNT/ B gene ...
2009 NOV 3 ... due to the risk of potential contamination with Clostridium botulinum, which can cause botulism, a serious and sometimes life-threatening condition. Consumers should not use these ...
2009 SEP 7 ... "Coordinated small-molecule drug discovery research efforts for the treatment of botulism by the public sector, especially the U.S. Department of Defense (DoD) and Department of ...
2009 SEP 8 ... proteins responsible for neurotransmitter release, causing the neuroparalytic disease botulism. BoNT serotypes B, D, F and G cleave and inactivate vesicle-associated membrane protein ...
2009 SEP 7 ... for a BoNT therapeutic over the period from 1975-2007. Two antitoxin preparations: Human botulism immunoglobulin (BIG) and Botulism Immune Globulin ...
2009 AUG 3 ... Clostridium botulinum, Clostridium baratii and Clostridium butyricum,' new data in botulism. In this recently published study, investigators in Maisons-Alfort, France conducted a ...
2009 JUL 7 ... "Tetanus neurotoxin and botulinum neurotoxins are the causative agents of tetanus and botulism. They block the release of neurotransmitters from synaptic vesicles in susceptible ...
2009 JUL 14 ... to a study from the United States, "California has an ongoing epidemic of wound botulism (WB) among injection drug users (IDUs). We retrospectively studied a cohort of patients ...
2009 JUL 20 ... "Even with mild neurological signs, patients with botulism frequently complain of autonomic symptoms. This study aimed at the evaluation of ...
2009 NOV 23 ... USA Inc. (NYSE: AGN). Botox (onabotulinumtoxin A), produced by the bacterium that causes botulism, is highly toxic to humans. Hart received 300 units of Botox on Aug. 20, ...
2009 NOV 1 ... Switzerland, "Botulinum neurotoxins, predominantly serotypes C and D, cause equine botulism through forage poisoning. The C-terminal part of the heavy chain of botulinum neurotoxin ...
